Number of abnormal oral glucose tolerance test time-points and risk of adverse perinatal outcomes in gestational diabetes: a retrospective cohort study
Year: 2026
Type: article
Study design: Observational Study
Abstract: Background Gestational diabetes mellitus (GDM) is diagnosed when any one of three 75-g oral glucose tolerance test (OGTT) values is abnormal, but whether the number of abnormal time-points adds prognostic information beyond this binary diagnosis is unsettled. Methods In this single-centre retrospective cohort, 700 women with a complete 75-g OGTT at 24–28 weeks of gestation were classified as normoglycaemic (n=351; all three values below IADPSG thresholds) or GDM (n=349), the latter as GDM-1 (one abnormal time-point; n=176), GDM-2 (two; n=134) or GDM-3 (three; n=39). The pre-specified primary outcome was a composite of preterm birth <37 weeks, macrosomia ≥4000 g, neonatal hypoglycaemia and neonatal asphyxia, excluding policy-dependent neonatal unit transfer; a five-component composite including transfer was secondary. Logistic regression adjusted for maternal age, pre-pregnancy body mass index and parity; Firth penalised regression addressed sparse outcomes, with Benjamini–Hochberg control for secondary outcomes. Results The primary composite occurred in 9.4% (33/351), 18.2% (32/176), 18.7% (25/134) and 41.0% (16/39) (trend P<0.001). Adjusted odds ratios versus normoglycaemia were 1.95 (95% CI 1.15–3.33), 1.87 (1.04–3.35) and 5.42 (2.50–11.71); pooled GDM 2.18 (1.38–3.44). The per-time-point odds ratio within GDM was 1.44 (0.98–2.11; P = 0.065). The five-component composite showed the same ordering (23.4%, 31.2%, 35.1%, 46.2%) with odds ratios of 1.40 (0.93–2.11), 1.55 (0.99–2.44) and 2.51 (1.24–5.10). After additional adjustment for early-pregnancy fasting glucose, gestational weight gain, insulin treatment and glycaemic control, the primary association persisted (pooled odds ratio 1.79, 1.11–2.90). Estimates were robust in bootstrap and sensitivity analyses. Conclusions The number of abnormal OGTT time-points identifies women at higher risk of adverse perinatal outcomes independently of the policy-sensitive transfer component, but the relation is not graded: GDM-1 and GDM-2 were indistinguishable and the excess risk was concentrated in GDM-3 (39 women, 16 events); all phenotype-specific estimates therefore remain exploratory. The count is best interpreted as a readily available marker of glycaemic severity for risk stratification rather than as an independent causal exposure or a validated subtype. Women with a single abnormal value remained at increased risk, so de-escalated management is not supported.
Source: Frontiers in Endocrinology
Institution: Guangxi Medical University
Language: English
Subfield: Obstetrics and Gynecology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W7226018997
